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THE EXPRESSION OF INHERITED 
METABOLIC DISEASE IN CULTURED CELLS*t 
ALEXANDER G. BEARN 
Department of Medicine, 
The New York Hospital-Cornell Medical Center, 
New York, New York 
I. INTRODUCTION
T 
HE Harvey Society of New York was founded 70 years ago to 
commemorate the name of one who, with the publication of De 
Motu Cordis, provided definitive evidence for the circulation of blood 
and established the abiding, but then novel, principle that scientists 
should not complacently recycle the conventional wisdom of the past. 
Rather they should, and I now use Harvey's stirring imperative, "Search 
out and study the secrets of Nature by way of experiment." 
Harvey, in addition to being a scientist was a busy medical practi­
tioner, and in the course of his daily practice, he might well have 
encountered patients suffering from inherited disease. While Harvey is, 
of course, best known for De Motu Cordis, he published in the 73rd 
year of his life, his second great work De Generatione Animalium. 
Although a scrutiny of De Generatione failed to provide the hoped for 
evidence that Harvey was aware of the existence of inherited disease, 
there is an extraordinary letter extant, first quoted in full by Garrod in 
his Harveian Lecture in 1924 (Garrod, 1924), which shows that Harvey 
was 300 years ahead of his time in appreciating that the study of rare 
diseases clarifies normal biological and biochemical mechanisms. Har­
vey's last correspondent was Dr. Jon Vlackfeld, a practitioner living in 
Haarlem who had consulted him regarding a patient of his that was 
suffering from stone (Keynes, 1966) (Fig. 1). The paucity of any 
documentary evidence bearing on Harvey's medical interests can be 
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Learned Sir, 
There has come to me your very pleasant letter, in which you show both 
extreme goodwill towards myself and also exceptional industry in the cultivation 
of our art. 
It is indeed so. Nature is nowhere wont to reveal her innermost secrets more 
openly than where she shows faint traces of herself away from the beaten track. 
Nor is there any surer route to the proper practice of medicine than if someone 
gives his mind over to discerning the customary law of Nature through the careful 
investigation of diseases that are of rare occurrence. Indeed, in practically all 
things it is apparently arranged that we scarcely perceive what is useful or most 
serviceable in them unless some are lacking in these features or have a faulty 
disposition. The case of the plasterer you mention is certainly an unique instance, 
in the elucidation of which it is possible for much discussion to arise. But it is 
useless for you to spur me on and for me to gird myself for some new research 
when I am not only ripe in years but also-let me admit-a little weary. It seems 
to me, indeed, that I am entitled to ask for an honourable discharge. On the other 
hand, it will always be a pleasure to me to see distinguished gentlemen such as 
yourself engaged in such worthy contest. Farewell, elegant Sir, and whatever you 
do, continue to hold in affection 
Yours respectfully, 
William Harvey 
London, 24 April 1657 
FIG. 1. William Harvey's reply to a letter from Dr. Jon Vlackfeld of Haarlem. 
Harvey died later that year. 
laid, at least in part, on governmental interference. With the execution 
of Charles I, Harvey lost his patient and his friend. He loathed the 
Parliamentary regime that followed·, and they in turn, showed no 
fondness for him. In a remarkable action, Parliament expressly forbade 
him to come within 20 miles of the City of London even to those of his 
patients.who needed medical attention (Whitteridge, 1971 ). 
Not content with this infringement of liberty, Parliament in the 
winter of 1642-1643 plundered Harvey's lodgings at Whitehall and 
pillaged not only his worldly goods but his entire medical records. And, 
when in 1666 the Great Fire destroyed the College, all hope of learning 
more about the medical interests of William Harvey was gone forever 
(Whitteridge, 1971, 1974). 
An interesting historical link between the Harvey Society and ge­
netics arises from the fact that in the same year that the Harvey 
Society was founded in New York, William Bateson made the sug­
gestion that the word "Genetics" be used to cover the emerging field of 
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hereditary variation (Bateson, 1928). The ensuing 70 years have 
seen the science of genetics emerge as the axial thread of biology with 
great relevance not only to those whose principal activities are rooted in 
laboratory research of the most fundamental sort, but also to physi­
cians whose primary concern is the alleviation of suffering and the 
prevention and treatment of disease. 
Since 1900 improvements in general hygiene, and the development of 
antibiotic therapy have enabled many of the epidemic infectious dis­
eases, particularly those of infancy and early childhood, increasingly to 
be controlled. In contrast, the morbidity and mortality of diseases of 
genetic origin have been little affected. A recent survey of the patients 
in the Department at New York Hospital-Cornell Medical Center, 
disclosed that no less than 12% of patients admitted to the adult 
medical service suffer from diseases in which a genetic component can 
be recognized (Childs et al., 1972). It is variously estimated that 
approximately 3% of the population at birth are afflicted with a 
genetically determined disease, a figure that would be even more 
substantial if the base line consisted of all zygotes conceived, rather 
than infants born. The rapid increase in the number of inherited 
conditions that are now known is illustrated in Fig. 2. 
II. HISTORICAL DEVELOPMENT
Ross Harrison, in his Harvey Lecture delivered in 1908, described 
experiments that marked the dawn of modern tissue culture (Harrison, 
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FIG. 2. Recognition of human gene loci (1966-1974). (After McKusick, 1975.) 
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1908). When the embryonic spinal cord of the frog surrounded by 
lymph was sealed in a chamber, the cord cells not only remained viable, 
but from them there developed the outgrowth of nerve axons. These 
observations, at one and the same time provided the coup de grace to 
those who were still stubbornly adhering to the view that the nerve 
axon and the nerve cell were separate and unconnected bodies, and also 
established the powerful usefulness of cell culture in answering impor­
tant biological questions. Here at The Rockefeller Institute, Harrison's 
observations were quickly seized upon by Alexis Carrel. Carrel found, 
all too quickly, that a major deterrent to the successful cultivation of 
cells in vitro was the frequency with which they became contaminated 
with bacteria. To combat this difficulty, Carrel devised complicated and 
bizarrely arcane rituals, including insistence that a black gown and cap 
were a necessary prerequisite for those who would dare to venture on 
the treacherous seas of tissue culture. Slowly, however, black magic and 
alchemy yielded to science and orthodoxy, and tissue culture as a tool 
in biological research is now firmly established (Carrel, 1964; Beam, 
1972). 
The rational use of cell culture as an investigative technique in 
inherited metabolic disease is rooted in the simple biologic truth that, 
since a full complement of chromosomes is present in all somatic cells, 
it should be possible to detect the specific biochemical consequences of 
gene activity in cultured fibroblasts unless, during the process of dif­
ferentiation, genes are irreversibly inactivated. 
III. THE HURLER AND HUNTER SYNDROMES
Rather more than 10 years ago, our laboratory embarked on an 
investigation to see whether the inherited mucopolysaccharidoses could 
be studied profitably in cultured fibroblasts. The mucopolysacchari­
doses are rare inborn errors of metabolism, to use the phrase introduced 
by Garrod in his epoch making Croonian Lectures in 1908 (Garrod, 
1908), that result in an accumulation of mucopolysaccharides in vari­
ous issues of the body. The diseases are characterized by mental 
deficiency and dwarfism, as well as a variety of other signs and symptoms 
(McKusick, 1972). The two most common forms of the disease are 
colloquially known as Hurler's syndrome and Hunter's syndrome, the 
former being autosomally inherited, the latter X-linked. 
An increased hepatic storage of mucopolysaccharides in patients 
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dying from the disease was first reported by Brante (1952). Later 
Dorfman and Lorinz (1957), and Meyer and associates (1958) reported 
an increased urinary excretion of mucopolysaccharides in these dis­
eases. In 1965, Berggftrd extended these studies in our laboratory, and 
although he was able to confirm the increased urinary excretion of 
mucopolysaccharides in patients affected with the disease, he was 
unable to distinguish clinically unaffected heterozygous carriers from 
normal subjects (Berggftrd and Beam, 1965). He made the interesting 
prediction that, since both dermatan sulfate and heparan sulfate con­
tained iduronic acid and since both mucopolysaccharides were excreted 
in excess in the urine, "the mutations might affect enzymes partici­
pating in the metabolism of iduronic acid" (Berggftrd and Beam, 1965). 
In an attempt to circumvent the time-consuming chemical determina­
tions necessary to identify specific mucopolysaccharides, we first inves­
tigated the possibility that histological methods could be used to 
identify the presence of mucopolysaccharides in cells grown in tissue 
culture. 
It is well known that the thiazine dye toluidine blue O will form 
complexes with a variety of negatively charged tissue components. 
When they do so, there is a shift in the absorption maxima of the dye 
toward a shorter wavelength. This will result in metachromasia, a 
change in color from the orthochromatic blue through violet to red. A 
certain minimum surface charge density is required for metachromasia 
to become apparent. Thus, with the polysaccharide hyaluronic acid, 
where the distance between the carboxyl groups is 19-30 A, meta­
chromasia is usually not evident. However, with the introduction of 
sulfate ester groups, the intercharge difference is sharply reduced and 
results in strong and stable red metachromasia. Thus the mucopolysac­
charides dermatan sulfate, heparan sulfate and keratan sulfate all stain 
metachromatically. 
Fibroblasts derived from patients with the Hurler and Hunter syn­
dromes show distinct cytoplasmic metachromasia (Danes and Beam, 
1966a), which can be shown by chemical methods to be due to 
increased cellular uronic acid. The cells derived from the heterozygous 
parents of the autosomally inherited Hurler syndrome show a similar 
metachromatic appearance. Although these tinctorial alterations also 
indicate that the heterozygous carrier can be detected in tissue culture, 
the degree of staining is similar in both affected individuals and unaf­
fected heterozygotes, and the test cannot be used to distinguish hetero-
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zygotes in the general population. In the X-linked Hunter syndrome, 
the cells derived from the carrier mother also show similar staining 
characteristics. Cloning experiments performed on cells derived from 
the X-linked mothers of patients with Hunter syndrome indicate the 
presence of two distinct tinctorial pop'ulations (Danes and Beam, 
1967). In the metachromatic population it appears that the X chromo­
some bearing the normal gene has been inactivated, whereas in the 
population of cells which show no metachromasia the chromosome 
bearing the abnormal gene has been inactivated. These findings provide 
additional experimental evidence for the validity of the Lyon hypoth­
esis (1962). In contrast, all cells derived from the mothers of patients 
with the autosomally inherited Hurler's syndrome show metachromasia, 
confirming that the Lyon hypothesis does not obtain for the auto­
somes. 
The co-cultivation of cells derived from patients with the Hurler 
syndrome and the Hunter syndrome result in a population of cells 
which, by their tinctorial characteristics, cannot be distinguished from 
those derived from normal individuals. The corrective factors have been 
extensively investigated by Neufeld and her co-workers (Fratantoni et
al., 1968; Neufeld, 1973), who showed that the rapid accumulation of 
sulfated mucopolysaccharides that occurs when the cells from Hurler 
syndrome and Hunter syndrome are cultivated in vitro does not arise if 
the two cell populations are mixed (Fig. 3). In addi�ion, they also 
showed that correction can be obtained by the use of culture medium 
and does not require cell-to-cell contact. 
Additional studies by Neufeld have shown the specific enzyme sul­
foiduronate sulfatase is deficient in the cells of patients with the Hunter 
syndrome whereas a-L-iduronidase is deficient in the cells of patients 
with the Hurler syndrome. It was of particular interest that O'.-L-iduroni­
dase was also decreased in the Scheie syndrome, as variant of the Hurler 
syndrome, in which intellectual function is preserved (Fig. 4) (Neufeld, 
1974). The observation that the same enzyme was apparently affected 
in both raised the possibility that the two syndromes are euallelic, in 
the same way that the genes controlling the synthesis of hemoglobin S 
and hemoglobin C are euallelic: Euallelism would permit the existence 
of mixed Hurler/Scheie heterozygotes analogous to hemoglobin 
S/hemoglobin C heterozygotes. At least eight patients have now been 
identified in whom the clinical phenotype has features of both the 
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FIG. 3. Accumulation of mucopolysaccharides (MPS) in normal cells(--), 
in in vitro-cultivated Hurler syndrome( .... ) and Hunter syndrome (- - - -) cells, 
and in mixed Hurler and Hunter syndromes cells(·-·-). After Neufeld (1973). 
Hurler and Hunter syndromes and in whom there is a deficiency of 
a-L-iduronidase (McKusick et al., 1972). Kinetic and metabolic studies
should help to clarify, at the molecular level, possible structural and
functional differences between the enzymes defective in the two syn­
dromes.
The usefulness of tissue culture in investigating inherited metabolic 
disease does not rest with the biochemical identification of the primary 
defect. The cells in culture provide a model system of the disease, 
which can be used to test the possible effectiveness of therapeutic 
agents. The administration of purified enzyme to patients in whom an 
enzyme is defective will not be effective unless the enzyme gains access, 
and in sufficient quantities, to the cell compartment where the enzymic 
function is required. Although it has not proved to be therapeutically 
beneficial, it is of interest, in view of its known action on lysosomes, 
that vitamin A can reverse the tinctorial characteristics of the mutant 
cells when added in vitro (Danes and Beam, 1966b ). Although the 
elucidation of the biochemical defect in patients with most of the 
known mucopolysaccharidoses has now been accomplished there are 
many inherited diseases, far more common than the mucopolysacchari­
doses, where the underlying defect remains utterly obscure. 
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FIG. 4. Normal degradation of dermatan sulfate. (After Neufeld, 1974).
IV. CYSTIC FIBROSIS OF THE PANCREAS
Cystic fibrosis is the most frequently occurring autosomally inherited 
disease -affecting the white population (Table I). It occurs in all popula-
. tions but appears to be distinctly less common in the Oriental and 
Black populations. The disease was probably first recognized by Garrod 
and Hurtley (1912), who believed it was an inherited disorder of fat 
metabolism in which fats were not absorbed from the alimentary tract 
in normal quantities .. He was led to believe that the disease was 
autosomally inherited since the normal parents of the affected sibs were 
first cousins. [It is of some interest that, in fact, an increased consan­
guinity would not be expected in a homogeneous recessively inherited 
disease of the frequency of cystic fibrosis.] The first clue that there 
might be a biochemical defect in cystic fibrosis came from astute 
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clinical observations. The late summer of 1948 was characterized by a 
heat wave of short duration but high intensity, and in the space of 4 
days, 10 patients were admitted to the Babies Hospital of the College of 
Physicians and Surgeons with heat stroke, six of whom had cystic 
fibrosis (Fig. 5) (Kessler and Andersen, 1951 ). It was quickly appre­
ciated that if the patients with cystic fibrosis lost excessive salt in their 
sweat compared to the four other patients, an explanation for the 
circulatory collapse would be at hand. Studies by di Sant' Agnese and 
his colleagues (1953) demonstrated an increased sweat sodium in the 
patients with cystic fibrosis, and an increased sweat sodium is now the 
most reliable diagnostic test for the disease, particularly in childhood. 
The increased sweat sodium is now recognized to be the consequence of 
the presence of a factor, known colloquially as the Mangos factor after 
its discoverer, which is present in the sweat of patients with the disease 
and inhibits the normal reabsorption of salt (Mangos and McSherry, 
1967). The factor occurs in small quantities and, apart from knowing 
that it is protein in nature, its isolation and characterization has been 
difficult. As a result of the studies on the defect in salt excretion, the 
view gained prominence that the disease was primarily a disorder of the 
exocrine system, a view that gained credence from the known abnor­
mality in pancreatic and bronchial secretions. However, in view of our 
findings with the mucopolysaccharidoses and because in principle the 
genetic defect should be present in every cell, we turned to tissue 
culture, using the same techniques that had previously been useful in 
investigating the mucopolysaccharidoses. 
The initial studies indicated that, as in the mucopolysaccharidoses, 
the cells derived from patients with cystic fibrosis showed meta­
chromasia (Danes and Beam, 1969a). This metachromasia, which also 
TABLE I 
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FIG. 5. Relation of ambient temperature to patients admitted to Babies Hospi­
tal, New York City, with circulatory collapse (August-September 1948). ■, Cystic 
fibrosis; �. non-cystic fibrosis. 1 rectangle represents 1 patient. After Kessler and 
Andersen (1951). 
occurred in the heterozygotes, could not be distinguished from that 
occurring in the mucopolysaccharidoses and certain other diseases. 
However, the increased mucopolysaccharide content so characteristic of 
the mucopolysaccharidoses was not regularly observed in the cells from 
patients with cystic fibrosis (Danes and Beam, 1969b ). Moreover, 
whereas the cells from patients with the mucopolysaccharidoses stained 
with alcian blue at high electrolyte concentrations, the cells from the 
cystic fibrosis patients did not (Danes et al., 1970). As the study 
progressed, it was apparent that not all patients with cystic fibrosis had 
metachromatically stained fibroblasts and, further, that the proportion 
of patients showing metachromasia differed in different populations 
(Table II). Although there does not appear to be a clear-cut correlation 
between the presence or the absence of metachromasia and the clinical 
findings, recent studies by Danes et al. (1975), in which they studied an 
adult population of patients with cystic fibrosis at the Brampton 
Hospital, the frequency of metachromasia was found to be over 90% 
(Table II). It cannot be sufficiently emphasized that, although meta­
chromasia is usually observed in the heterozygous parents of patients in 
whom metachromasia is present, the test is difficult, at times unpre­
dictable, and cannot be used to detect heterozygotes with the disease. 
This is further emphasized by those families in whom this cell marker 
cannot be detected even in those clinically affected (Beam and Danes, 
1969). 
In 1956, Alexander Spock made the curious but important observa­
tion that serum from patients with cystic fibrosis contained a substance 
INHERITED METABOLIC DISEASE 
TABLE II 




Population patients Metachromatic Ametachromatic 
New York City 30 26 4 (13%) 
Minneapolis 27 22 5 (19%) 
Denmark 87 56 31 (35%) 
England (adults) 42 39 3 (7%) 
that had the property of disorganizing the synchronous movements of 
oyster cilia derived from rabbit tracheal ex plants (Spock et al., 1967). 
This factor, now known as the Spock factor, bears some similarity to 
the Mangos factor in that it is protein in nature. As with the Mangos 
factor, isolation and detailed characterization of the factor has been 
difficult. 
A systematic attempt to investigate other ciliated organisms, in an 
effort to find a simpler biological system, led Bowman and her col­
leagues to investigate oyster cilia (Bowman et al., 1969, 1970, 1973). 
Although many investigators prefer the rabbit tracheal system (Conover 
et al., 1973), we have used the oyster (Crassostrea virginica) in our 
studies in cystic fibrosis. 
Although the addition of normal serum had no effect on the syn­
chronous beating of oyster cilia, the addition of serum from patients 
with cystic fibrosis, as well as the serum of patients who are hetero­
zygous carriers, usually caused the cessation of movement within 60 
seconds. The test, like nearly all biological tests, is highly variable and 
very subjective. Duplicate samples must always be obtained and the 
tests run in a double-blind fashion. Even when these precautions are 
taken, there are many occasions when the test is unsatisfactory. In the 
summer months, as Bowman has shown, the excessive production of 
mucus by the oyster makes the test essentially useless (Lockhart and 
Bowman, 1973). Despite these limitations, the test is providing con­
crete evidence of the presence of a substance in the serum of most 
patients with cystic fibrosis which inhibits the cilia. It is also of interest 
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that serum from heterozygous as well as homozygous individuals, which 
consistently does not inhibit the cilia, is usually derived from patients 
in whom metachromasia is not apparent in their cultured cells. 
Although the isolation and characterization of cystic fibrosis from 
cystic fibrosis serum has not been accomplished, a number of properties 
have been described (Bowman et al., 1973; Danes et al., 1973; Bow­
man, 1973). Prominent among these has been the finding that the 
factor is associated with the ')'-globulin fraction of serum (Fig. 6). 
However, the possibility that the factor was itself an antibody was 
excluded by the immunological studies of Bowman and her colleagues 
(Herzberg et al., 1973). Synthesis of the factor by cultured fibroblasts 
was established by growing cells derived from patients with cystic 
fibrosis in a synthetic protein-free medium. When purified lgG was 
added to the protein-free cultured fluid, the cystic fibrosis factor 
emerged associated with lgG in the void volume (Fig. 7). The properties 
of cystic fibrosis compiled from several sources are summarized in 
Table III. 
Although the appearance of the "factor" in the serum of patients is 
of extreme interest, its exact nature and its relevance to the primary 
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FIG. 6. Serum protein fraction derived from patient with cystic fibrosis sepa­
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FIG. 7. Cystic fibrosis factor activity in serum-free culture medium. Dowex 
1-2X, chloride (0.9 X 44 cm). o--o, Addition of 3 mg/ml of IgGl - - -•, no
IgGl added.
inborn errors of metabolism, is one that affects a specific enzyme. It is 
possible that the presence of the factor in the serum represents the 
accumulation of a substance behind an enzymatic metabolic block. The 
cystic fibrosis factor, according to this hypothesis, might be a normal 
serum component that occurs in increased concentration in patients 
with cystic fibrosis. The small molecular weight of the cystic fibrosis 
factor raised the possibility, among the many others, that the factor 
TABLE III 




Reaction with serum proteins 
Binds: 
No binding: 
4,500-10,000 Daltons (Gel filtration Ainicon filters) 
pH 9.10-9.30 
Pepsin pH 3.8 
Papain pH 8.5 
Heat 50°C for 15 min 
IgG (IgGl, IgG2) �
2 
M, heavy chains 


































FIG. 8. Fusion of human fibroblasts and mouse hepatoma cells yield a hybrid that synthesizes immunologically 
det�ctable human serum albumin. Control studies indicate the specificity of the albumin synthesized. Abbreviations: FIB, 
Fibroblasts; HSA, Human serum albumin; MSA, Mouse serum albumin; HEP, Mouse hepatoma; FCS, Fetal calf serum; 
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might be related to the complement system. This possibility has been 
investigated by Conover and his colleagues (1973b) as well as by 
ourselves (Polley and Beam, 1974). An outline of the preliminary 
studies carried out in our laboratory indicate that the third component 
of compiement is usually decreased; in addition there is a decreased 
conversion of C3 proactivator (Polley and Beam, 1974). Moreover, the 
incubation of purified C3 by trypsin under conditions that split C3 into 
C3a and smaller tryptic fragments indicates that the small-molecular­
weight peptides inhibit oyster cilia whereas C3, as well as the split 
products C3b and C3a, have no inhibitory effect (Polley and Beam, 
197 5). Although further studies on the possible relevance of the com­
plement system to cystic fibrosis are in progress, it seems likely that 
any abnormality in this system is of secondary importance. 
Although the application of cell culture to investigating inherited 
metabolic disease has been restricted, in this presentation, to two main 
groups of diseases, more than 70 inherited diseases have been investi­
gated using these techniques, and their number continues to increase. 
Already, many of these diseases can be detected prenatally by the 
cultivation of fetal cells obtained by amniocentesis, and in those in­
stances where prenatal detection can be reliably performed the pos­
sibility of selective abortion can be entertained. 
The recent use of mouse hepatoma human hybrids as developed by 
Darlington and her colleagues (1974) has raised the possibility that 
under appropriate experimental conditions liver-specific proteins, such 
as serum albumin, can be synthesized by normal human fibroblasts. The 
synthesis of human serum albumin by cultured fibroblasts following the 
fusion of mouse hepatoma cells with normal human fibroblasts is 
illustrated in Fig. 8. If, as seems likely, the findings obtained thus far 
can be extended to other organ-specific proteins, the possibility arises 
that inherited diseases in which the metabolic abnormality appears to 
be restricted to a specific differentiated organ may be approached by 
the use of cell hybridization techniques. It is clear that the usefulness of 
cell culture in the study of inherited disease is still in its infancy. 
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ADDENDUM (July 1976) 
In the 18 months that have elapsed since the delivery of this lecture, the 
primary metabolic defects in most of the mucopolysaccharidoses have been 
determined. The number of inherited diseases detectable in tissue culture con­
tinues to increase and the number of instances where accurate prenatal diagnosis 
can be made is also increasing rapidly (McKusick, 1975). Although the number of 
reported metabolic aberrations in cystic fibrosis shows no signs of abatement, the 
primary enzymatic defect remains elusive. 
